High-Dose Vitamin D3 Administration Is Associated With Increases in Hemoglobin Concentrations in Mechanically Ventilated Critically Ill Adults: A Pilot Double-Blind, Randomized, Placebo-Controlled Trial - PubMed (original) (raw)
Randomized Controlled Trial
High-Dose Vitamin D3 Administration Is Associated With Increases in Hemoglobin Concentrations in Mechanically Ventilated Critically Ill Adults: A Pilot Double-Blind, Randomized, Placebo-Controlled Trial
Ellen M Smith et al. JPEN J Parenter Enteral Nutr. 2018 Jan.
Abstract
Background: Anemia and vitamin D deficiency are highly prevalent in critical illness, and vitamin D status has been associated with hemoglobin concentrations in epidemiologic studies. We examined the effect of high-dose vitamin D therapy on hemoglobin and hepcidin concentrations in critically ill adults.
Materials and methods: Mechanically ventilated critically ill adults (N = 30) enrolled in a pilot double-blind, randomized, placebo-controlled trial of high-dose vitamin D3 (D3 ) were included in this analysis. Participants were randomized to receive placebo, 50,000 IU D3 , or 100,000 IU D3 daily for 5 days (totaling 250,000 IU D3 and 500,000 IU D3 , respectively). Blood was drawn weekly throughout hospitalization for up to 4 weeks. Linear mixed-effects models were used to assess change in hemoglobin and hepcidin concentrations by treatment group over time.
Results: At enrollment, >75% of participants in all groups had plasma 25-hydroxyvitamin D (25(OH)D) concentrations <30 ng/mL, and >85% of participants across groups were anemic. In the 500,000-IU D3 group, hemoglobin concentrations increased significantly over time (Pgroup × time = .01) compared with placebo but did not change in the 250,000-IU D3 group (Pgroup × time = 0.59). Hepcidin concentrations decreased acutely in the 500,000-IU D3 group relative to placebo after 1 week (P = .007). Hepcidin did not change significantly in the 250,000-IU D3 group.
Conclusion: In these critically ill adults, treatment with 500,000 IU D3 was associated with increased hemoglobin concentrations over time and acutely reduced serum hepcidin concentrations. These findings suggest that high-dose vitamin D may improve iron metabolism in critical illness and should be confirmed in larger studies.
Keywords: anemia; critical illness; hemoglobin; hepcidin; vitamin D.
© 2016 American Society for Parenteral and Enteral Nutrition.
Conflict of interest statement
Conflicts of interest: JHS and RJK are employed by Eli Lilly and Company and performed the hepcidin assay. Eli Lilly and Company played no role in the study design or the decision to publish.
Figures
Figure 1
Geometric mean hemoglobin concentrations with corresponding 95% confidence intervals in critically ill adults. Hemoglobin concentrations are reported across time and by treatment group. Hemoglobin concentrations increased significantly over time in the group that received 500,000 IU D3 compared to the placebo group; there was no significant change in the 250,000 IU D3 group. By three weeks, hemoglobin concentrations in the 500,000 IU D3 group differed significantly from the placebo group; there were no statistically significant differences between groups at other time points. *P<0.05; group*time, group-by-time interaction. Sample sizes in the placebo, 250,000 IU D3, and 500,000 IU D3 groups, respectively: enrollment n = 10, 9, 11; 1 week n = 9, 9, 9; 2 weeks n = 8, 6, 5; 3 weeks n = 5, 4, 2; 4 weeks n = 2, 2, 1.
Figure 2
Geometric mean hepcidin concentrations with corresponding 95% confidence intervals in critically ill adults. Hepcidin concentrations are reported across time and by treatment group. There were no significant differences over time in hepcidin concentrations in either vitamin D-treated group relative to placebo. Hepcidin concentrations in the 500,000 IU D3 group differed significantly from the placebo group one week after dosing; there were no statistically significant differences between groups at other time points. *P<0.05; group*time, group-by-time interaction. Sample sizes in the placebo, 250,000 IU D3, and 500,000 IU D3 groups, respectively: enrollment n = 10, 9, 11; 1 week n = 9, 6, 9; 2 weeks n = 8, 6, 5; 3 weeks n = 4, 4, 2.
Similar articles
- Impact of high-dose vitamin D3 on plasma free 25-hydroxyvitamin D concentrations and antimicrobial peptides in critically ill mechanically ventilated adults.
Han JE, Alvarez JA, Jones JL, Tangpricha V, Brown MA, Hao L, Brown LAS, Martin GS, Ziegler TR. Han JE, et al. Nutrition. 2017 Jun;38:102-108. doi: 10.1016/j.nut.2017.02.002. Epub 2017 Feb 27. Nutrition. 2017. PMID: 28526374 Free PMC article. Clinical Trial. - High-dose vitamin D3 reduces circulating hepcidin concentrations: A pilot, randomized, double-blind, placebo-controlled trial in healthy adults.
Smith EM, Alvarez JA, Kearns MD, Hao L, Sloan JH, Konrad RJ, Ziegler TR, Zughaier SM, Tangpricha V. Smith EM, et al. Clin Nutr. 2017 Aug;36(4):980-985. doi: 10.1016/j.clnu.2016.06.015. Epub 2016 Jun 27. Clin Nutr. 2017. PMID: 27402475 Free PMC article. Clinical Trial. - Short-term effects of high-dose oral vitamin D3 in critically ill vitamin D deficient patients: a randomized, double-blind, placebo-controlled pilot study.
Amrein K, Sourij H, Wagner G, Holl A, Pieber TR, Smolle KH, Stojakovic T, Schnedl C, Dobnig H. Amrein K, et al. Crit Care. 2011;15(2):R104. doi: 10.1186/cc10120. Epub 2011 Mar 28. Crit Care. 2011. PMID: 21443793 Free PMC article. Clinical Trial. - Effect of high-dose vitamin D3 on hospital length of stay in critically ill patients with vitamin D deficiency: the VITdAL-ICU randomized clinical trial.
Amrein K, Schnedl C, Holl A, Riedl R, Christopher KB, Pachler C, Urbanic Purkart T, Waltensdorfer A, Münch A, Warnkross H, Stojakovic T, Bisping E, Toller W, Smolle KH, Berghold A, Pieber TR, Dobnig H. Amrein K, et al. JAMA. 2014 Oct 15;312(15):1520-30. doi: 10.1001/jama.2014.13204. JAMA. 2014. PMID: 25268295 Clinical Trial. - A Prospective Study to Evaluate the Possible Role of Cholecalciferol Supplementation on Autoimmunity in Hashimoto's Thyroiditis.
Bhakat B, Pal J, Das S, Charaborty SK, SircarMedical NR, Kolkata, RGKar, NorthBengal, Siliguri. Bhakat B, et al. J Assoc Physicians India. 2023 Jan;71(1):1. J Assoc Physicians India. 2023. PMID: 37116030 Clinical Trial.
Cited by
- Has a High Dose of Vitamin D3 Impacted Health Conditions in Older Adults?-A Systematic Review and Meta-Analysis Focusing on Dose 100,000 IU.
Owczarek B, Ziomkiewicz A, Łukowska-Chojnacka E. Owczarek B, et al. Nutrients. 2024 Jan 14;16(2):252. doi: 10.3390/nu16020252. Nutrients. 2024. PMID: 38257146 Free PMC article. Review. - The effect of high-dose vitamin D supplementation on hepcidin-25 and erythropoiesis in patients with chronic kidney disease.
Pistis KD, Westerberg PA, Qureshi AR, Beshara S, Sterner G, Bárány P, Linde T. Pistis KD, et al. BMC Nephrol. 2023 Jan 25;24(1):20. doi: 10.1186/s12882-022-03014-z. BMC Nephrol. 2023. PMID: 36698076 Free PMC article. Clinical Trial. - Antioxidant, anti-inflammatory and immunomodulatory roles of vitamins in COVID-19 therapy.
Pisoschi AM, Pop A, Iordache F, Stanca L, Geicu OI, Bilteanu L, Serban AI. Pisoschi AM, et al. Eur J Med Chem. 2022 Mar 15;232:114175. doi: 10.1016/j.ejmech.2022.114175. Epub 2022 Feb 4. Eur J Med Chem. 2022. PMID: 35151223 Free PMC article. Review. - Rapid and Effective Vitamin D Supplementation May Present Better Clinical Outcomes in COVID-19 (SARS-CoV-2) Patients by Altering Serum INOS1, IL1B, IFNg, Cathelicidin-LL37, and ICAM1.
Gönen MS, Alaylıoğlu M, Durcan E, Özdemir Y, Şahin S, Konukoğlu D, Nohut OK, Ürkmez S, Küçükece B, Balkan İİ, Kara HV, Börekçi Ş, Özkaya H, Kutlubay Z, Dikmen Y, Keskindemirci Y, Karras SN, Annweiler C, Gezen-Ak D, Dursun E. Gönen MS, et al. Nutrients. 2021 Nov 12;13(11):4047. doi: 10.3390/nu13114047. Nutrients. 2021. PMID: 34836309 Free PMC article.
References
- Corwin HL, Gettinger A, Pearl RG, et al. The CRIT Study: Anemia and blood transfusion in the critically ill--current clinical practice in the United States. Crit Care Med. 2004 Jan;32(1):39–52. - PubMed
- Vincent JL, Baron JF, Reinhart K, et al. Anemia and blood transfusion in critically ill patients. JAMA. 2002;288(12):1499–1507. - PubMed
- Retter A, Wyncoll D, Pearse R, et al. Guidelines on the management of anaemia and red cell transfusion in adult critically ill patients. Br J Haematol. 2013;160(4):445–464. - PubMed
- Pieracci FM, Stovall RT, Jaouen B, et al. A multicenter, randomized clinical trial of IV iron supplementation for anemia of traumatic critical illness. Crit Care Med. 2014;42(9):2048–2057. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- K01 DK102851/DK/NIDDK NIH HHS/United States
- K24 DK096574/DK/NIDDK NIH HHS/United States
- T32 DK007298/DK/NIDDK NIH HHS/United States
- UL1 TR000454/TR/NCATS NIH HHS/United States
- UL1 TR002378/TR/NCATS NIH HHS/United States
- L30 DK106709/DK/NIDDK NIH HHS/United States
- T32 DK007734/DK/NIDDK NIH HHS/United States
- R21 HL110044/HL/NHLBI NIH HHS/United States
- TL1 TR000456/TR/NCATS NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical